David E. Maslow

508 total citations
22 papers, 434 citations indexed

About

David E. Maslow is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Biomedical Engineering. According to data from OpenAlex, David E. Maslow has authored 22 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 5 papers in Biomedical Engineering. Recurrent topics in David E. Maslow's work include Retinal Development and Disorders (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Pluripotent Stem Cells Research (2 papers). David E. Maslow is often cited by papers focused on Retinal Development and Disorders (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Pluripotent Stem Cells Research (2 papers). David E. Maslow collaborates with scholars based in United States. David E. Maslow's co-authors include E. Mayhew, L. Weiss, Youcef M. Rustum, Francis C. Szoka, Gabor Markus, Victor P. Terranova, Barbara P. Schick, James D. San Antonio, Martin H. Goldrosen and N. Tolson and has published in prestigious journals such as Science, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

David E. Maslow

21 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David E. Maslow United States	11	196	100	85	80	68	22	434
T. Ohnishi United States	13	271 1.4×	141 1.4×	46 0.5×	38 0.5×	166 2.4×	18	665
G. S. Adair United Kingdom	7	213 1.1×	123 1.2×	157 1.8×	24 0.3×	103 1.5×	11	759
William S. Craig	8	244 1.2×	55 0.6×	60 0.7×	42 0.5×	57 0.8×	10	418
Takaaki Akaike Japan	8	145 0.7×	76 0.8×	20 0.2×	71 0.9×	71 1.0×	8	597
Koong-Nah Chung United States	10	316 1.6×	73 0.7×	111 1.3×	63 0.8×	28 0.4×	13	551
Michael Wassler United States	13	305 1.6×	38 0.4×	75 0.9×	43 0.5×	78 1.1×	20	567
Sandrine A. Tinton Belgium	11	510 2.6×	48 0.5×	78 0.9×	86 1.1×	33 0.5×	13	719
Gary Lange United States	12	205 1.0×	37 0.4×	49 0.6×	33 0.4×	68 1.0×	16	641
Yukio Ueno Japan	12	183 0.9×	30 0.3×	28 0.3×	41 0.5×	22 0.3×	20	477
Ninfa G. Lopez United States	10	462 2.4×	112 1.1×	95 1.1×	53 0.7×	25 0.4×	11	603

Countries citing papers authored by David E. Maslow

Since Specialization

Citations

This map shows the geographic impact of David E. Maslow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Maslow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Maslow more than expected).

Fields of papers citing papers by David E. Maslow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Maslow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Maslow. The network helps show where David E. Maslow may publish in the future.

Co-authorship network of co-authors of David E. Maslow

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Maslow. A scholar is included among the top collaborators of David E. Maslow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Maslow. David E. Maslow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schick, Barbara P., et al.. (2003). Novel concatameric heparin-binding peptides reverse heparin and low-molecular-weight heparin anticoagulant activities in patient plasma in vitro and in rats in vivo. Blood. 103(4). 1356–1363. 37 indexed citations

Terranova, Victor P., David E. Maslow, & Gabor Markus. (1989). Directed migration of murine and human tumor cells to collagenases and other proteases.. PubMed. 49(17). 4835–41. 32 indexed citations

Maslow, David E. & Martin H. Goldrosen. (1988). Relationship of in vitro cell motility and colonization potential in a mouse colon adenocarcinoma (MCA-38) cell line.. PubMed. 8(3). 133–42. 15 indexed citations

Mayhew, E., et al.. (1982). Characterization, toxicity and therapeutic efficacy of adrïamycin encapsulated in liposomes. European Journal of Cancer and Clinical Oncology. 18(2). 167–176. 154 indexed citations

Maslow, David E., E. Mayhew, & Charles E. Wenner. (1982). Some effects of the tumor promoter 12-0-tetradecanoylphorbol 13-acetate on cell interactions in vitro.. PubMed. 69(3). 721–4. 1 indexed citations

Maslow, David E., E. Mayhew, & Arnold Mittleman. (1981). Cells from Normal and Malignant Human Colon Mucosa Differentially Inhibit Embryonic Cell Aggregation. Oncology. 38(5). 292–294.

Maslow, David E. & J. P. Harlos. (1981). The effect of neuraminidase- and ribonuclease-susceptible surface anionic groups on the aggregation of embryonic chick neural retina cells. Journal of Cell Science. 51(1). 229–240. 5 indexed citations

Maslow, David E., et al.. (1980). Differential Inhibition of In Vitro Malignant Cell Assays by B16 Mouse Melanoma Variants<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 64(3). 635–7. 3 indexed citations

Maslow, David E. & L. Weiss. (1979). Contribution of macrophages to interactions between tumor cells and other tissues assessed in an in vitro system. International Journal of Cancer. 24(4). 450–454. 2 indexed citations

10.

Maslow, David E. & L. Weiss. (1978). The effects of tumour cells on embryonic cell aggregation, adhesion and detachment. Journal of Cell Science. 29(1). 271–275. 4 indexed citations

11.

Maslow, David E., E. Mayhew, & Jun Minowada. (1976). Differential inhibition of embryonic cell aggregation by cultured human cells with "malignant" of "normal" characteristics.. PubMed. 36(8). 2707–9. 6 indexed citations

12.

Maslow, David E. & L. Weiss. (1976). Some effects of positively charged surface groups on cell aggregation. Journal of Cell Science. 21(2). 219–225. 12 indexed citations

13.

Maslow, David E. & E. Mayhew. (1975). Inhibition of Embryonic Cell Aggregation by Neoplastic Cells2. JNCI Journal of the National Cancer Institute. 54(5). 1097–1102. 6 indexed citations

14.

Mayhew, E., et al.. (1974). Cellular binding of ³H‐cytochalasin B. Journal of Cellular Physiology. 84(3). 373–382. 32 indexed citations

15.

Maslow, David E. & E. Mayhew. (1974). Histotypic cell aggregation in the presence of cytochalasin b. Journal of Cell Science. 16(3). 651–663. 7 indexed citations

16.

Maslow, David E.. (1973). Incorporation and release of 51 Cr and 14 C-labeled amino acids in Ehrlich ascites carcinoma cells.. PubMed. 14(2). 84–8. 1 indexed citations

17.

Maslow, David E. & L. Weiss. (1972). Cell exudation and cell adhesion. Experimental Cell Research. 71(1). 204–208. 37 indexed citations

18.

Weiss, L. & David E. Maslow. (1972). Some effects of trypsin dissociation on the inhibition of reaggregation among embryonic chicken neural retina cells by cycloheximide. Developmental Biology. 29(4). 482–485. 8 indexed citations

19.

Maslow, David E.. (1970). Electrokinetic surfaces of trypsin-dissociated embryonic chick liver cells. Experimental Cell Research. 61(2-3). 266–270. 19 indexed citations

20.

Maslow, David E.. (1969). Cell specificity in the formation of multinucleated striated muscle. Experimental Cell Research. 54(3). 381–390. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact